FDA Drug Application (201889) for RASAGILINE MESYLATE by ALKEM LABS LTD

Back to FDA Applications sponsored by ALKEM LABS LTD

Application Number201889
Product Number001
FormTABLET;ORAL
Dosage0.5MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRASAGILINE MESYLATE
Active IngredientRASAGILINE MESYLATE

Active IngredientCount
List of drugs with Active Ingredient RASAGILINE MESYLATE2


Back to FDA Applications sponsored by ALKEM LABS LTD